<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36589219</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2434-9194</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>Global health &amp; medicine</Title><ISOAbbreviation>Glob Health Med</ISOAbbreviation></Journal><ArticleTitle>Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant.</ArticleTitle><Pagination><StartPage>322</StartPage><EndPage>326</EndPage><MedlinePgn>322-326</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.35772/ghm.2022.01069</ELocationID><Abstract><AbstractText>Although Omicron appears to cause less severe acute illness than the original strain, the potential for large numbers of patients to experience long COVID is a major concern. Little is known about the recovery phase in cases of Omicron, highlighting the importance of dynamically monitor long COVID in those patients. Subjects of the current study were patients available for a three-month follow-up who were admitted from January 13 to May 22, 2020 (period of the original strain) and from January 1 to May 30, 2022 (period of Omicron). Twenty-eight-point-four percent of patients infected with the original strain had long-term symptoms of COVID-19 and 5.63% of those infected with the Omicron strain had such symptoms. The most common symptom was a cough (18.5%), followed by tightness in the chest (6.5%), in patients infected with the original strain. Fatigue (2.4%) and dyspnea (1.7%) were the most commonly reported symptoms in patients infected with the Omicron strain. The respiratory system is the primary target of SARSCoV-2. Supportive treatment is the basis for the treatment of respiratory symptoms in patients with COVID-19. Quality sleep and good nutrition may alleviate fatigue and mental issues. Further knowledge about a long-term syndrome due to Omicron needs to be discussed and assembled so that healthcare and workforce planners can rapidly obtain information to appropriately allocate resources.</AbstractText><CopyrightInformation>2022, National Center for Global Health and Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Xuejiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Qibin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Zhenghua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Jingke</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Guoqin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Sumei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bengbu Medical College, Bengbu, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bengbu Medical College, Bengbu, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Zhonghui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bengbu Medical College, Bengbu, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Hongyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Hongzhou</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, Bio-therapeutic Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Glob Health Med</MedlineTA><NlmUniqueID>101771579</NlmUniqueID><ISSNLinking>2434-9186</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Omicron variant</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long-term sequelae</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>2</Day><Hour>3</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36589219</ArticleId><ArticleId IdType="pmc">PMC9773225</ArticleId><ArticleId IdType="doi">10.35772/ghm.2022.01069</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO. WHO Coronavirus (COVID-19) Dashboard. 
https://covid19.who.int/ (accessed September 1, 2022). </Citation></Reference><Reference><Citation>El-Shabasy RM, Nayel MA, Taher MM, Abdelmonem R, Shoueir KR, Kenawy ER. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic. Int J Biol Macromol. 2022; 204:161-168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782737</ArticleId><ArticleId IdType="pubmed">35074332</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, et al. . The conundrum of 'long-COVID-19': A narrative review. Int J Gen Med. 2021; 14:2491-2506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021; 75:e14357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022; 399:2263-2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo MDM, Foppiani A, Peretti GM, Mangiavini L, Battezzati A, Bertoli S, Martinelli Boneschi F, Zuccotti GV. Long-term coronavirus disease 2019 complications in inpatients and outpatients: A one-year follow-up cohort study. Open Forum Infect Dis. 2021; 8:ofab384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344801</ArticleId><ArticleId IdType="pubmed">34386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. . Female gender is associated with long COVID syndrome: A prospective cohort study. Clin Microbiol Infect. 2022; 28:611. e9-611e16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, M&#xfc;ller B, Merle U. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): A prospective cohort study. Clin Infect Dis. 2022; 74:1191-1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324:603-605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Bravi B, Poletti S, Furlan R, Ciceri F; COVID-19 BioB Outpatient Clinic Study group, Rovere-Querini P, Benedetti F. One-year mental health outcomes in a cohort of COVID-19 survivors. J Psychiatr Res. 2021; 145:118-124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8607816</ArticleId><ArticleId IdType="pubmed">34894521</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021; 397:220-232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021; 398:747-758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Li Y, Shao TR, Yang LL, Li SJ, Wang XJ, Li A, Wu YY, Liu XF, Liu CM, Liu YH, Zeng F, Cen Y. Some characteristics of clinical sequelae of COVID-19 survivors from Wuhan, China: A multi-center longitudinal study. Influenza Other Respir Viruses. 2022; 16:395-401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652839</ArticleId><ArticleId IdType="pubmed">34796652</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivani F, Kumari N, Bai P, Rakesh F, Haseeb M, Kumar S, Jamil A, Zaidi M, Shaukat F, Rizwan A. Long-term symptoms of COVID-19: One-year follow-up study. Cureus. 2022; 14:e25937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9282616</ArticleId><ArticleId IdType="pubmed">35844318</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Health Commission &amp; State Administration of Traditional Chinese Medicine. Protocol for diagnosis and treatment of COVID-19 (interim 9th edition). 
http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml (accessed Septembr 15, 2022). (in Chinese) .</Citation></Reference><Reference><Citation>
World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance, 28 January 2020. 
https://apps.who.int/iris/handle/10665/330893?locale-attribute=en&amp;
(accessed Septembr 17, 2022).</Citation></Reference><Reference><Citation>Wang J, Zhu K, Xue Y, Wen G, Tao L. Research Progress in the Treatment of Complications and Sequelae of COVID-19. Front Med (Lausanne). 2021; 8:757605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674502</ArticleId><ArticleId IdType="pubmed">34926504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010; 15:543-550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, Eyre L, Breen A, O'Connor R, Jones A, Sivan M. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med. 2020; 52:jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>